Left ventricular dysfunction predicted by early troponin I release after high-dose chemotherapy
Top Cited Papers
- 1 August 2000
- journal article
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 36 (2), 517-522
- https://doi.org/10.1016/s0735-1097(00)00748-8
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Phase II Trial of High-Dose Liposome-Encapsulated Doxorubicin With Granulocyte Colony-Stimulating Factor in Metastatic Breast CancerJournal of Clinical Oncology, 1999
- Cardiac effects of high-dose epirubicin and cyclophosphamide in women with poor prognosis breast cancerAnnals of Oncology, 1999
- Cardiac Troponin T Levels for Risk Stratification in Acute Myocardial IschemiaThe New England Journal of Medicine, 1996
- Relation Between Troponin T and the Risk of Subsequent Cardiac Events in Unstable Coronary Artery DiseaseCirculation, 1996
- High-dose chemotherapy with hematopoietic rescue as primary treatment for metastatic breast cancer: a randomized trial.Journal of Clinical Oncology, 1995
- Anthracyclines and the heart.Heart, 1993
- The Prognostic Value of Serum Troponin T in Unstable AnginaThe New England Journal of Medicine, 1992
- Mobilization of peripheral blood progenitor cells by chemotherapy and granulocyte-macrophage colony-stimulating factor for hematologic support after high-dose intensification for breast cancerBlood, 1992
- Reversibility of Severe Left Ventricular Dysfunction Due to Doxorubicin CardiotoxicityAnnals of Internal Medicine, 1987
- Doxorubicin cardiac toxicity manifesting seven years after treatment. Case report and reviewAmerican Journal Of Medicine, 1986